US Drug Recall Register
Class III · Low risk Terminated Initiated Aug 8, 2018 (8 years ago)

Azelastine HCl Ophthalmic Solution 0.05%

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Impurities/Degradation Specifications:out-of-specification (OOS) results for Azelastine N-oxide

What was recalled

Azelastine HCl Ophthalmic Solution 0.05%, 6 mL in 10 mL HDPE bottle, 1 bottle per box, Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-718-10

Recalling firm
Akorn, Inc.
NDC code
17478-718-10
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1168-2018

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Azelastine recalls

See all
Class II · Moderate risk Ongoing

Azelastine Hydrochloride Nasal Spray

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0787-2023
Class II · Moderate risk Terminated

Dymista

Reason Defective Container: Potential for broken glass in the neck area of the glass bottles.

Mylan Pharmaceuticals Inc. NDC 0037-0245-23 D-0424-2019
Class II · Moderate risk Terminated

Dymista

Reason Presence of foreign substance: Potential for glass in the neck area of the glass bottles.

Mylan Pharmaceuticals Inc. NDC 0037-0245-23 D-1075-2018
Class III · Low risk Terminated

Azelastine HCl Nasal Solution

Reason Sun Pharmaceutical is recalling Azelastine HCl Nasal Solution, 0.1% (30 mL Bottle) following a failure to meet the % RSD requirement in the test for Droplet Size during the 6 month long term stability test station

Sun Pharmaceutical Industries, Inc. NDC 47335-779-91 D-0417-2018